Genetic-based, differential susceptibility to paraquat neurotoxicity in mice

Neurotoxicology and Teratology

Volumn 33, Issue 3, 2011, Pages 415-421

  Yin, Lina ^a   Lu, Lu ^b,c   Prasad, Kavita ^d   Richfield, Eric K ^d   Unger, Erica L ^a   Xu, Jialin ^a   Jones, Byron C ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c NANTONG UNIVERSITY   (China)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

Gene expression; Inbred mice; Paraquat; Parkinson's disease; Substantia nigra

Indexed keywords

IRON; PARAQUAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DBA 2 MOUSE; DOPAMINERGIC NERVE CELL; FEMALE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; MALE; MESENCEPHALON; MICROARRAY ANALYSIS; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SUBSTANTIA NIGRA PARS COMPACTA;

ANIMALS; BRAIN; CELL COUNT; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; IMMUNOHISTOCHEMISTRY; IRON; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; NEURONS; NEUROTOXICITY SYNDROMES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARAQUAT; SPECIES SPECIFICITY; TISSUE DISTRIBUTION;

MUS;

EID: 79957811989     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2011.02.012     Document Type: Article

References (40)

1. Barbeau A., Cloutier T., Roy M., Plasse L., Paris S., Poirier J. Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine. Lancet 1985, 2:1213-1216.
2. Bartzokis G., Cummings J.L., Markham C.H., Marmarelis P.Z., Treciokas L.J., Tishler T.A., et al. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging 1999, 17:213-222.
3. Berg D., Gerlach M., Youdim M.B., Double K.L., Zecca L., Riederer P., et al. Brain iron pathways and their relevance to Parkinson's disease. J Neurochem 2001, 79:225-236.
4. Boone E.M., Cook M.N., Hou X., Jones B.C. Sex and strain influence the effect of ethanol on central monoamines. J Stud Alcohol 1997, 58:590-599.
5. Bromilow R.H. Paraquat and sustainable agriculture. Pest Manag Sci 2004, 60:340-349.
6. Brooks A.I., Chadwick C.A., Gelbard H.A., Cory-Slechta D.A., Federoff H.J. PQ elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res 1999, 27:1-10.
7. Castello P.R., Drechsel D.A., Patel M. Mitochondria are a major source of PQ-induced reactive oxygen species production in the brain. J Biol Chem 2007, 282:14186-14193.
8. Choi W.S., Kruse S.E., Palmiter R.D., Xia Z. Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or PQ. Proc Natl Acad Sci U S A 2008, 105:15136-15141.
9. Churchill G.A., Airey D.C., Allayee H., Angel J.M., Attie A.D., Beatty J., et al. The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet 2004, 36:1133-1137.
10. Cochemé H.M., Murphy M.P. Complex I is the major site of mitochondrial superoxide production by PQ. J Biol Chem 2008, 283:1786-1798.
11. Cook R., Lu L., Gu J., Williams R.W., Smeyne R.J. Identification of a single QTL, Mptp1, for susceptibility to MPTP-induced substantia nigra pars compacta neuron loss in mice. Brain Res Mol Brain Res 2003, 110:279-288.
12. Darvasi A., Soller M. A simple method to calculate resolving power and confidence interval of QTL map location. Behav Genet 1997, 27:125-132.
13. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
14. Erikson K.M., Pinero D.J., Connor J.R., Beard J.L. Regional brain iron, ferritin and transferrin concentrations during iron deficiency and iron repletion in developing rats. J Nutr 1997, 127:2030-2038.
15. Fernagut P.O., Hutson C.B., Fleming S.M., Tetreaut N.A., Salcedo J., Masliah E., et al. Behavioral and histopathological consequences of PQ intoxication in mice: effects of alpha-synuclein over-expression. Synapse 2007, 61:991-1001.
16. Golts N., Snyder H., Frasier M., Theisler C., Choi P., Wolozin B. Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein. J Biol Chem 2002, 277:16116-16123.
17. Gwinn-Hardy K. Genetics of parkinsonism. Mov Disord 2002, 17:645-656.
18. Hamre K., Tharp R., Poon K., Xiong X., Smeyne R.J. Differential strain susceptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP; administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus. Brain Res 1999, 15:91-103.
19. Hertzman C., Wiens M., Bowering D., Snow B., Calne D. Parkinson's disease: a case-control study of occupational and environmental risk factors. Am J Ind Med 1990, 17:349-355.
20. Kutner M., Nachtsheim C., Neter J., Li W. Applied linear statistical models 2004, McGraw-Hill. 5th edition.
21. Landrigan P.J., Sonawane B., Butler R.N., Trasande L., Callan R., Droller D. Early environmental origins of neurodegenerative disease in later life. Environ Health Perspect 2005, 113:1230-1233.
22. Liou H.H., Tsai M.C., Chen C.J., Jeng J.S., Chang Y.C., Chen S.Y., et al. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 1997, 48:1583-1588.
23. Manning-Bog A.B., McCormack A.L., Li J., Uversky V.N., Fink A.L., Di Monte D.A. The herbicide PQ causes up-regulation and aggregation of alpha-synuclein in mice: PQ and alpha-synuclein. J Biol Chem 2002, 277:1641-1644.
24. McCormack A.L., Thiruchelvam M., Manning-Bog A.B., Thiffault C., Langston J.W., Cory-Slechta D.A., et al. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide PQ. Neurobiol Dis 2002, 10:119-127.
25. McCormack A.L., Atienza J.G., Johnston L.C., Andersen J.K., Vu S., Di Monte D.A. Role of oxidative stress in PQ-induced dopaminergic cell degeneration. J Neurochem 2005, 93:1030-1037.
26. Peirce J.L., Lu L., Gu J., Silve L.M., Williams R.W. A new set of BXD recombinant inbred lines from advanced intercross populations in mice. BMC Genet 2004, 29:5-7.
27. Peng J., Mao X.O., Stevenson F.F., Hsu M., Andersen J.K. The herbicide PQ induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway. J Biol Chem 2004, 279:32626-32632.
28. Peng J., Peng L., Stevenson F.F., Doctrow S.R., Andersen J.K. Iron and PQ as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration. J Neurosci 2007, 27:6914-6922.
29. Prasad K., Richfield E.K. Sporadic midbrain dopamine neuron abnormalities in laboratory mice. Neurobiol Dis 2008, 32:262-272.
30. Prasad K., Richfield E.K. Number and nuclear morphology of TH+ and TH- neurons in the mouse ventral midbrain using epifluorescence stereology. Exp Neurol 2010, 225:328-340.
31. Prasad K., Winnik B., Thiruchelvam M.J., Buckley B., Mirochnitchenko O., Richfield E.K. Prolonged toxicokinetics and toxicodynamics of PQ in mouse brain. Environ Health Perspect 2007, 115:1448-1453.
32. Prasad K., Tarasewicz E., Mathew J., Strickland P.A., Buckley B., Richardson J.R., et al. Toxicokinetics and toxicodynamics of PQ accumulation in mouse brain. Exp Neurol 2009, 215:358-367.
33. Rhodes S.L., Ritz B. Genetics of iron regulation and the possible role of iron in Parkinson's disease. Neurobiol Dis 2008, 32:183-195.
34. Richardson J.R., Quan Y., Sherer T.B., Greenamyre J.T., Miller G.W. PQ neurotoxicity is distinct from that of MPTP and rotenone. Toxicol Sci 2005, 88:193-201.
35. Shimizu K., Matsubara K., Ohtaki K., Fujimaru S., Saito O., Shiono H. PQ induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats. Brain Res 2003, 976:243-252.
36. Schmitz C., Hof P.R. Design-based stereology in neuroscience. Neuroscience 2005, 130:813-831.
37. Sofic E., Paulus W., Jellinger K., Riederer P., Youdim M.B. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 1991, 56:978-982.
38. Thiruchelvam M., Richfield E.K., Baggs R.B., Tank A.W., Cory-Slechta D.A. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J Neurosci 2000, 20:9208-9214.
39. Thiruchelvam M.J., Powers J.M., Cory-Slechta D.A., Richfield E.K. Risk factors for dopaminergic neuron loss in human alpha-synuclein transgenic mice. Eur J Neurosci 2004, 19:845-854.
40. Winnik B., Barr D.B., Thiruchelvam M., Montesano M.A., Richfield E.K., Buckley B. Quantification of paraquat, MPTP, and MPP+ in brain tissue using microwave assisted solvent extraction (MASE) and high performance liquid chromatography-mass spectrometry. Anal Bioanal Chem 2009, 395:195-201.